Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Jul 8;23(11):1879–1886. doi: 10.1016/j.bbmt.2017.06.026

Figure 1.

Figure 1

(A) OS for all adult and pediatric MPAL from time of disease diagnosis. (B) OS for all patients by MPAL subtypes from time of disease diagnosis. (C) OS by MPAL who underwent HCT by MPAL subtype from time of transplant. (D) Estimated cumulative incidence of relapse after HCT by MPAL subtype. In figure C and D a separate curve for the single MPAL NOS patient who underwent HCT is not presented; however, this patient is included in the curve showing HCT outcome of all MPAL.